The biosimilar breakthrough in adoption and affordability

The pharmaceutical industry is at a crossroads of care where biosimilars can transform how we manage—and mitigate—rising specialty drug costs. To understand key trends shaping the future of biosimilars, Evernorth Research Institute examined biosimilar utilization patterns and the influence of market forces in the latest Pharmacy in Focus report “The biosimilar breakthrough in adoption and affordability”.